新冠肺炎的成本和检测的成本效益

IF 2.5 3区 经济学 Q2 ECONOMICS
B. López-Valcárcel, L. Vallejo-Torres
{"title":"新冠肺炎的成本和检测的成本效益","authors":"B. López-Valcárcel, L. Vallejo-Torres","doi":"10.1108/AEA-11-2020-0162","DOIUrl":null,"url":null,"abstract":"\nPurpose\nThis paper aims to provide an estimation of the costs of the coronavirus (COVID-19) pandemic with a special focus on Spain. Costs include macroeconomic costs of foregone gross domestic product (GDP) attributable to the pandemic and the direct and indirect costs of prevention, treatment and lost productivity. This study also analyzes the cost-effectiveness of the test-tracking-quarantine (TTQ) strategy in Spain.\n\n\nDesign/methodology/approach\nThe macroeconomic costs of foregone GDP attributable to the pandemic are estimated for different countries and areas by comparing the present GDP forecasts for 2020 and 2021 with counterfactuals estimated before the COVID-19 crisis aftermath. The total cost of the COVID-19 for Spain in 2020 was obtained using the cost of illness approach with a bottom-up process. A cost-effectiveness analysis of the TTQ strategy in Spain is based on the estimation of the total costs of TTQ and the health gains and avoided health-care costs associated with the TTQ strategy. A sensitivity analysis explores the consequences of uncertainty in key parameters.\n\n\nFindings\nThe GDP cost of the COVID-19 is by far larger than all the other components of the cost. The global cost of the Covid-19 crisis in 2020–2021 is estimated at 14% of 2019 GDP (around 12,206 mm$). In the specific case of Spain, it amounts to 24% of the 2019 GDP; which is 397.3 m €. Spain is and will be by far the European country most economically affected by the pandemic. In Spain 2020, the GDP cost accounts for 94.7% of the total cost of the COVID-19 and health-care direct costs are only 2.14%. TTQ is a dominant strategy in Spain. For each euro spent on it, 7 euros will be recovered only in terms of saved health-care resources.\n\n\nResearch limitations/implications\nGiven the large degree of uncertainty and the fast-evolving nature of the epidemic, a number of assumptions are required to arrive at the estimates provided in this study. The results were found to be robust to the assumptions applied.\n\n\nPractical implications\nTTQ is a key strategy for the contention of the epidemy and it is justified from the economic perspective.\n\n\nOriginality/value\nThis is the first estimation of the cost of the COVID-19 and the cost-effectiveness of the TTQ strategy for Spain.\n","PeriodicalId":36191,"journal":{"name":"Applied Economic Analysis","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2021-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"21","resultStr":"{\"title\":\"The costs of COVID-19 and the cost-effectiveness of testing\",\"authors\":\"B. López-Valcárcel, L. Vallejo-Torres\",\"doi\":\"10.1108/AEA-11-2020-0162\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\nPurpose\\nThis paper aims to provide an estimation of the costs of the coronavirus (COVID-19) pandemic with a special focus on Spain. Costs include macroeconomic costs of foregone gross domestic product (GDP) attributable to the pandemic and the direct and indirect costs of prevention, treatment and lost productivity. This study also analyzes the cost-effectiveness of the test-tracking-quarantine (TTQ) strategy in Spain.\\n\\n\\nDesign/methodology/approach\\nThe macroeconomic costs of foregone GDP attributable to the pandemic are estimated for different countries and areas by comparing the present GDP forecasts for 2020 and 2021 with counterfactuals estimated before the COVID-19 crisis aftermath. The total cost of the COVID-19 for Spain in 2020 was obtained using the cost of illness approach with a bottom-up process. A cost-effectiveness analysis of the TTQ strategy in Spain is based on the estimation of the total costs of TTQ and the health gains and avoided health-care costs associated with the TTQ strategy. A sensitivity analysis explores the consequences of uncertainty in key parameters.\\n\\n\\nFindings\\nThe GDP cost of the COVID-19 is by far larger than all the other components of the cost. The global cost of the Covid-19 crisis in 2020–2021 is estimated at 14% of 2019 GDP (around 12,206 mm$). In the specific case of Spain, it amounts to 24% of the 2019 GDP; which is 397.3 m €. Spain is and will be by far the European country most economically affected by the pandemic. In Spain 2020, the GDP cost accounts for 94.7% of the total cost of the COVID-19 and health-care direct costs are only 2.14%. TTQ is a dominant strategy in Spain. For each euro spent on it, 7 euros will be recovered only in terms of saved health-care resources.\\n\\n\\nResearch limitations/implications\\nGiven the large degree of uncertainty and the fast-evolving nature of the epidemic, a number of assumptions are required to arrive at the estimates provided in this study. The results were found to be robust to the assumptions applied.\\n\\n\\nPractical implications\\nTTQ is a key strategy for the contention of the epidemy and it is justified from the economic perspective.\\n\\n\\nOriginality/value\\nThis is the first estimation of the cost of the COVID-19 and the cost-effectiveness of the TTQ strategy for Spain.\\n\",\"PeriodicalId\":36191,\"journal\":{\"name\":\"Applied Economic Analysis\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2021-02-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"21\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Applied Economic Analysis\",\"FirstCategoryId\":\"96\",\"ListUrlMain\":\"https://doi.org/10.1108/AEA-11-2020-0162\",\"RegionNum\":3,\"RegionCategory\":\"经济学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ECONOMICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Applied Economic Analysis","FirstCategoryId":"96","ListUrlMain":"https://doi.org/10.1108/AEA-11-2020-0162","RegionNum":3,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ECONOMICS","Score":null,"Total":0}
引用次数: 21

摘要

本文旨在对冠状病毒(COVID-19)大流行的成本进行估算,并特别关注西班牙。成本包括因该流行病而丧失的国内生产总值的宏观经济成本,以及预防、治疗和生产力损失的直接和间接成本。本研究还分析了西班牙测试-跟踪-检疫(TTQ)战略的成本效益。设计/方法/方法通过将目前2020年和2021年的国内生产总值预测与COVID-19危机后估计的反事实进行比较,估计不同国家和地区因大流行而放弃的国内生产总值的宏观经济成本。西班牙2020年COVID-19的总成本是采用自下而上的疾病成本方法获得的。西班牙TTQ战略的成本效益分析是基于TTQ总成本以及与TTQ战略相关的保健收益和避免的保健费用的估计。敏感性分析探讨了关键参数不确定性的后果。2019冠状病毒病的GDP成本远远大于成本的所有其他组成部分。据估计,2020-2021年Covid-19危机的全球成本占2019年GDP的14%(约12.06亿美元)。在西班牙的具体情况下,它占2019年GDP的24%;也就是3.973亿欧元。到目前为止,西班牙是且将是受疫情影响最严重的欧洲国家。在西班牙2020年,GDP成本占COVID-19总成本的94.7%,医疗保健直接成本仅为2.14%。TTQ是西班牙的主要策略。在这方面每花费1欧元,只能从节省的保健资源中收回7欧元。研究局限性/影响考虑到很大程度的不确定性和该流行病的快速演变性质,需要若干假设才能得出本研究中提供的估计。结果对所应用的假设是稳健的。sttq是对抗疫情的关键策略,从经济角度来看是合理的。独创性/价值这是对2019冠状病毒病的成本和西班牙TTQ战略的成本效益的首次估计。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The costs of COVID-19 and the cost-effectiveness of testing
Purpose This paper aims to provide an estimation of the costs of the coronavirus (COVID-19) pandemic with a special focus on Spain. Costs include macroeconomic costs of foregone gross domestic product (GDP) attributable to the pandemic and the direct and indirect costs of prevention, treatment and lost productivity. This study also analyzes the cost-effectiveness of the test-tracking-quarantine (TTQ) strategy in Spain. Design/methodology/approach The macroeconomic costs of foregone GDP attributable to the pandemic are estimated for different countries and areas by comparing the present GDP forecasts for 2020 and 2021 with counterfactuals estimated before the COVID-19 crisis aftermath. The total cost of the COVID-19 for Spain in 2020 was obtained using the cost of illness approach with a bottom-up process. A cost-effectiveness analysis of the TTQ strategy in Spain is based on the estimation of the total costs of TTQ and the health gains and avoided health-care costs associated with the TTQ strategy. A sensitivity analysis explores the consequences of uncertainty in key parameters. Findings The GDP cost of the COVID-19 is by far larger than all the other components of the cost. The global cost of the Covid-19 crisis in 2020–2021 is estimated at 14% of 2019 GDP (around 12,206 mm$). In the specific case of Spain, it amounts to 24% of the 2019 GDP; which is 397.3 m €. Spain is and will be by far the European country most economically affected by the pandemic. In Spain 2020, the GDP cost accounts for 94.7% of the total cost of the COVID-19 and health-care direct costs are only 2.14%. TTQ is a dominant strategy in Spain. For each euro spent on it, 7 euros will be recovered only in terms of saved health-care resources. Research limitations/implications Given the large degree of uncertainty and the fast-evolving nature of the epidemic, a number of assumptions are required to arrive at the estimates provided in this study. The results were found to be robust to the assumptions applied. Practical implications TTQ is a key strategy for the contention of the epidemy and it is justified from the economic perspective. Originality/value This is the first estimation of the cost of the COVID-19 and the cost-effectiveness of the TTQ strategy for Spain.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Applied Economic Analysis
Applied Economic Analysis Economics, Econometrics and Finance-Economics, Econometrics and Finance (all)
CiteScore
3.50
自引率
4.30%
发文量
5
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信